MURF
NASDAQMurphy Canyon Acquisition Corp.
Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- 13D/GSEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- 13D/GSEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- SECSEC Form S-8 filed by Murphy Canyon Acquisition Corp.S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form 424B3 filed by Murphy Canyon Acquisition Corp.424B3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form EFFECT filed by Murphy Canyon Acquisition Corp.EFFECT - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- INSIDERSEC Form 4 filed by Lewis-Hall Freda C4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSEC Form 4 filed by Mcnealey Jennifer Isacoff4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSEC Form 4 filed by Bligh James4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSEC Form 4 filed by Farley Chele Chiavacci4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSEC Form 4 filed by Charles Faith L.4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSragovicz Adam was granted 74,545 units of Restricted Stock Units (SEC Form 4)4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- INSIDERSEC Form 4 filed by Tapolczay David4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
- SECSEC Form S-8 filed by Murphy Canyon Acquisition Corp.S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form S-1/A filed by Murphy Canyon Acquisition Corp. (Amendment)S-1/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form 10-Q/A filed by Murphy Canyon Acquisition Corp. (Amendment)10-Q/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form 10-Q filed by Murphy Canyon Acquisition Corp.10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form NT 10-Q filed by Murphy Canyon Acquisition Corp.NT 10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECSEC Form S-1 filed by Murphy Canyon Acquisition Corp.S-1 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- SECMurphy Canyon Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Amendments to the Registrant's Code of Ethics, or Waiver of a P8-K/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
- 13D/GSEC Form SC 13G filed by Murphy Canyon Acquisition Corp.SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- 13D/GSEC Form SC 13D/A filed by Murphy Canyon Acquisition Corp. (Amendment)SC 13D/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- 13D/GSEC Form SC 13D filed by Murphy Canyon Acquisition Corp.SC 13D - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- 13D/GSEC Form SC 13G filed by Murphy Canyon Acquisition Corp.SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
- SECMurphy Canyon Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Amendments to the Registrant's Code of Ethics, or Waiver of a P8-K - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
MURF FAQ
6 questionsWhat does Murphy Canyon Acquisition Corp. do?
Murphy Canyon Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, and adjacent businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in San...Where does MURF stock trade?
Murphy Canyon Acquisition Corp. (MURF) is listed on NASDAQ.What sector and industry is MURF in?
Murphy Canyon Acquisition Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Murphy Canyon Acquisition Corp. go public?
Murphy Canyon Acquisition Corp. (MURF) completed its IPO in 2022.What companies are similar to MURF?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare MURF side-by-side with any of them on Quantisnow.How can I track MURF on Quantisnow?
Quantisnow aggregates Murphy Canyon Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MURF to receive live email and push alerts on every new disclosure.